Ingevity Corporation (NGVT) Fair Value 2026

NGVT · Chemicals & Allied Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.3 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-07-15, Ingevity Corporation (NGVT) trades at $74.53, approximately 1127% above CirclFi’s Bayesian DCF fair value of $6.07. QOC: 3.3/10. Value Trap Risk: 18/100 (SAFE). 12/13 models active.

Key Facts

Ticker
NGVT
Price
$74.53
Quality Score
3.3/10
Value Trap Risk
18/100
Models Active
12/13
Last Updated
Strength: Earnings Power Value suggests +96.4% upside with 72% confidence
Risk: Below-average Quality Score of 3.3/10 signals weak fundamentals

Is Ingevity Corporation (NGVT) Undervalued or Overvalued in 2026?

According to CirclFi’s 12-model valuation engine, Ingevity Corporation (NGVT) appears overvalued as of : the median of 12 independent fair value estimates is $66.06, 11.4% below the current price of $74.53. Estimates range from $6.07 to $194.47. NGVT scores 3.3/10 on fundamental quality and 18/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Ingevity Corporation Stock in 2026? →

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($74.53)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$6.07 -91.9%
Earnings Power Value
High Conviction
$146.40 +96.4%
CUCE Ensemble
Low Conviction
$113.98 +52.9%
First Chicago
High Conviction
$83.46 +12.0%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Ingevity Corporation (NGVT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Ingevity Corporation at its current price of $74.53. The composite intrinsic value is estimated at $73.20 (-1.8% average return), with 7 models flagging overvaluation risk. Notably, FTNN sees the most upside at +160.9% (fair value: $194.47), while Bayesian DCF is the most conservative at -91.9% ($6.07). The spread between these extremes — +252.8% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.

What Do the Models Say About NGVT?

12 of 13 models are currently active for NGVT. Of these, 5 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates NGVT's intrinsic value at $6.07, implying -91.9% downside from the current price. See which stocks rank higher →

How Does NGVT Rank in Chemicals & Allied Products?

Among 14 Chemicals & Allied Products stocks, NGVT ranks #13 by Quality of Company score. CirclFi's QOC score of 3.3/10 evaluates 32 fundamental signals. A score of 3.3 signals below-average fundamentals.

As a manufacturing company, Ingevity Corporation operates in a sector where working capital efficiency is a critical driver of valuation. Investors evaluating NGVT should weigh these sector-specific dynamics alongside our model-derived fair values.

Is NGVT a Value Trap?

CirclFi's Value Trap algorithm assigns NGVT a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Ingevity Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Ingevity Corporation's fundamental quality profile registers 3.3/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +252.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NGVT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NGVT's 12 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Ingevity Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Chemicals & Allied Products Stocks Should You Also Analyze?

8 related Chemicals & Allied Products stocks with 13-model coverage

Read investment analysis: BCPC · SOLS · IOSP · FMC · ECVT

Frequently Asked Questions About Ingevity Corporation

What is Ingevity Corporation's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Ingevity Corporation (NGVT) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $6.07. The Quality of Company score is 3.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NGVT overvalued or undervalued right now?

At $74.53, 5 of 12 active models suggest NGVT may be undervalued, while 7 indicate potential overvaluation. The median of all 12 fair value estimates is $66.06, 11.4% below the current price of $74.53 — a consensus view that NGVT is overvalued. The assessment depends on which methodology best fits Ingevity Corporation's business model in Chemicals & Allied Products.

What does a Quality of Company score of 3.3 mean for NGVT?

Ingevity Corporation's QOC of 3.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on NGVT?

CirclFi analyzes NGVT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is NGVT a value trap in 2026?

Ingevity Corporation's Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 12-model valuation engine, Ingevity Corporation (NGVT) has a median fair value of $66.06 — 11.4% below the current price of $74.53 — as of 2026-07-15.” Source: circlfi.com/stock/NGVT/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on NGVT.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access